Startseite A mathematical model to study herbal and modern treatments against COVID-19
Artikel Öffentlich zugänglich

A mathematical model to study herbal and modern treatments against COVID-19

  • Arsène Jaurès Ouemba Tassé ORCID logo EMAIL logo , Berge Tsanou , Cletus Kwa Kum und Jean Lubuma
Veröffentlicht/Copyright: 11. März 2024
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

In this paper, we propose a two-group deterministic COVID-19 model which takes into account educational campaigns and the fact that people infected with COVID-19 may choose either modern (allopathic) medicine, traditional medicine or may combine the two modes of treatment. The model is analysed in the case where modern medicine is the only mode of treatment and when traditional medicine is taken as an adjuvant (or another mode of treatment). We prove in the first case that the model has a disease-free equilibrium (DFE), globally asymptotically stable when the control reproduction number is less than one and whenever it is greater than one, we prove the local asymptotic stability of the endemic equilibrium. In the second case, we prove that, misconceptions in the population lead to a backward bifurcation phenomenon, which makes the control of the disease more difficult. We derive using the Lyapunov method that a threshold T ensures the global asymptotic stability of DFE in some cases when its value is less than one. Both models are fitted using daily COVID-19 cumulative cases reported from January to February 2022 in South Africa. We found a control reproduction number less than one, meaning that COVID-19 will be eliminated. Comparison of the two models fits highlights that misconceptions should be taken into account to accurately describe the dynamics of COVID-19 in South Africa. Numerically, we prove that educational campaigns should focus on preventive measures and both traditional and allopathic medicine health care systems should complement each other in the fight against COVID-19.

1 Introduction

In December 2019, a serious disease known as the novel Coronavirus 2 (SARS-Cov-2 or COVID-19) was reported in Wuhan Province in China. It was declared a world-wide pandemic by the World Health Organization (WHO) on March 17, 2020 [1], [2]. COVID-19 is transmitted when people breathe in air contaminated by small airborne particles containing the virus. The air is contaminated by infected people who may or may not exhibit symptoms of the disease. Infected individuals spread the virus when they cough, sneeze or talk in proximity with other people who are not protected. To mitigate the spread of COVID-19, barriers measures such as physical distancing, wearing of face masks, self-quarantine; massive screening tests; isolation of infected and the vaccination are prescribed. The effectiveness of some of these measures to overcome the disease may be questionable as COVID-19 remains persistent to date. As of June 30, 2023, there have been more than 767,726,861 of confirmed COVID-19 cases and around 6,948,764 of deaths globally [3].

Individuals infected with COVID-19 present symptoms which are similar to those of flu. These symptoms include fever, cough, tiredness, loss of taste or smell and sometimes, diarrhoea, sore throat, headache, aches and pains [4]. At a critical stage they may have chest pain, difficulty in breathing, loss of speech and mobility. However, many of the infected cases are asymptomatic or present benign symptoms. Some infected people in Africa who have not been tested relate the disease to contagious respiratory illness caused by influenza viruses and they resort to natural products/traditional medicine for remedy.

The world health organization defines traditional medicine as the sum of the knowledge, skills and practices based on the theories, beliefs and experiences in different cultures, whether explicable or not, used in the maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical and mental illnesses [5]. Africa has a long history of traditional medicine and practitioners that play a crucial role in providing health care to the population. Many centuries before the introduction of modern medicine, African people depended solely on traditional medicine to treat and prevent human and animal diseases. WHO recognizes traditional, complementary and alternative medicine of proven quality, safety and efficacy [6], [7], [8], [9], [10]. However, the organization insists on supporting scientifically-proven traditional medicine. This is the bone of contention between advocates for traditional medicine and those for modern medicine.

Though the world health organization discourages the use of herbal remedies for the treatment of COVID-19 disease because of safety concerns, many infected people in Africa continue to seek herbal/traditional treatment or combine traditional medicine with modern medicine as adjuvants. Moreover, some governments have adopted many local products to treat COVID-19 patients. This brings to mind the Madagascar’s COVID-Organics which sparked controversy over its use for lack of sufficient scientific evidence or approval by global health authorities like WHO. COVID-Organics is an extract made from a local plants. This treatment was endorsed by the President of Madagascar, Andry Rajoelina in April 2020. Other African countries adopted (though not officially) local remedies for cure and prevention of COVID-19. For instance in Cameroon, Archbishop Samuel Kleda came up with two products: Elixir Covid and Adsak Covid; Dr. J. E. Azombo discovered Fagaricine and M. P. M. Ndi Samba in partnership with Dr. Peyou developed local Africa herbs that serve as a cure for COVID-19. Dr. Marlys developed a product called Ngul Be Tara or the power of ancestors to treat this pathology [11].

Despite ongoing debate on COVID-19 treatment, many people in Africa are either ignorant or do not believe in the existence of COVID-19. While some mistake the virus for influenza, there are some who associate the disease to witchcraft or to supernatural causes. Patients from these categories will prefer either self-treatment using natural products or visit herbalists rather than going to hospitals. The treatment is cheap, affordable and readily available. A study by [5] revealed that a good proportion of university staff and students used traditional medicine in treating COVID-19 disease during the South African nationwide lockdown. The COVID-19 pandemic is far from over, but no specific treatment for COVID-19 has proven 100 % effective and hence any effective treatment be in modern (mainstream) or traditional or a blend of the two will be of great relief to humanity. Biomathematicians with their mathematical models have an important role to play in this endeavour [12]. This is the motivation behind our model which incorporates among others parameters for modern and traditional medicines.

Many mathematical models are presented in literature to explain and predict evolution of the COVID-19 pandemic since its outbreak (see for instance [13], [14], [15], [16], [17] and references therein). Harjule et al. [13] presents a review of the various mathematical and statistical methods adopted so far to anticipate and analyse the outspread of the virus across the globe. In [17], a model is presented to evaluate the impact of control measures, such as quarantine and hospitalization on the spread of the corona virus. It is shown that when control measures are implemented, unreported symptomatic cases decrease faster than when control measures are neglected. The authors of the article [16] focus on the usefulness of contact tracing, quarantine and physical distancing in mitigating the intensity of COVID-19. Applying their model on data from Poland, they found out that contact tracing may be prevented in 50 % to 90 % of cases and that the effect of quarantine was limited by the number of undiagnosed cases. Furthermore, the disease could not be controlled without physical distancing measures. In the paper [15], the short-term forecasts of the COVID-19 pandemic in Cameroon was studied using a mathematical model. The model considers both direct transmission (human to human transmission) and indirect transmission due to the circulation of free Coronavirus in the environment. They discovered that, the former mode of transmission lead to more cases than the latter. Their results showed that, the number of COVID-19 cases will still increase and there is a necessity to improve the implementation of preventive measures. In [14], the influence of the presence of multi-strains of Coronavirus was investigated. The results confirmed that the alpha, beta and gamma variants are more transmissible than the original viral strain.

To the best of our knowledge and at the time of writing this paper, no author has investigated the role of traditional medicine in the control of the COVID-19 pandemic through mathematical modelling. In this work, we propose a two-group deterministic COVID-19 model which takes into account educational campaigns and the fact that people infected with COVID-19 may choose either modern (allopathic) medicine, traditional medicine or may combine the two modes of treatment. The model is analysed mathematically and numerically. In the case where infected people only recourse to modern medicine for their treatment, we prove that the disease-free equilibrium (DFE) is globally asymptotically stable (GAS) when the control reproduction number is less than one. When it is greater than one, we prove the existence of a unique endemic equilibrium, locally asymptotically stable (LAS). When people receive both modern and traditional treatment, we prove that the model has a backward bifurcation phenomenon. However, we derive a threshold T which ensures the elimination of the disease in some cases when its value is less than one. Numerical simulations are carried out to support mathematical analysis results. We fit the model to the daily cumulative cases of COVID-19 reported from January to February 2022 in South Africa and investigate the usefulness of educational campaigns, traditional and modern treatments. Sensitivity analysis of the model is performed to identify the most influential parameters on the dynamics of the model.

The rest of this article is partitioned as follows: In Section 2, the model and its quantitative analysis are presented in a comprehensive manner. Section 3 deals with the mathematical analysis and the illustration of some mathematical results. Model calibration and validation is presented in Section 4. The usefulness of educational campaigns and the place of each kind of treatment are presented in Section 5. Global sensitivity analysis in order to determine the most influential parameters is addressed in Section 6. The discussion is provided in Section 7.

2 Model formulation

2.1 Main assumptions and model variables

Our population is partitioned into two groups: those who prefer allopathic medicine for the treatment of COVID-19 and those who prefer traditional medicine. We use subscripts 1 and 2 to represent the groups of individuals, respectively. However, the dissemination of educative messages in favour of modern medicine may influence the choice of individuals within the population. Throughout this study, we will not consider messages which may influence people awareness of the disease (those who deny the existence of the disease). We assume that the amount of such messages is small comparatively with educative messages spread through social and audio–visual media and which are in line with the WHO recommendations. In addition, we assume that: (i) infected less informed persons who are influenced by the educative messages will seek modern treatment, (ii) patients choose only one mode of treatment and do not switch to another but may combine the two, (iii) SARS-Cov-2 virus confers permanent immunity. This assumption is supported by the fact that the number of individuals who contracted COVID-19 twice is low [14]. The notations and abbreviations used in this article are given in Table 9 (Appendix A). Our model is built on the following exclusive classes:

  1. S 1(t): Susceptible individuals who believe in the natural existence of the COVID-19 and trust that modern medicine is the right choice against the disease. We consider them as those who are aware or educated susceptible individuals.

  2. S 2(t): This compartment encompasses: (a) the susceptible individuals who mistake COVID-19 to influenza; (b) those who link the disease to witchcraft or other causes; (c) those who deny the existence of Sars-CoV-2 virus; (d) those who believe in traditional medicine for the treatment of the disease instead of the modern medicine. They are considered “uneducated” or “unaware” susceptible individuals throughout this paper.

  3. I 1(t) and I 2(t): Infected individuals who were formerly in the compartments S 1 and S 2, respectively, and not receiving any treatment actually.

  4. J(t): Infected individuals receiving modern medicine only (following the protocol recommended by the WHO [18]). This compartment is supplied by infected individuals found in sections I 1 and I 2.

  5. T(t): Infected individuals receiving traditional medicine only (follow-up by herbalists and spiritual healers). This compartment is supplied by individuals in niche I 2.

  6. C(t): Infected individuals who combine modern medicine and traditional medicine. These are patients who choose to combine the two modes of treatment.

  7. R(t): Recovered individuals.

The above variables are assumed to be of class C 1 continuously differentiable functions. The total population at time t, N(t), is given by:

N ( t ) = S 1 ( t ) + S 2 ( t ) + I 1 ( t ) + I 2 ( t ) + J ( t ) + T ( t ) + C ( t ) + R ( t ) ,

2.2 Model description

Our model follows the flowchart presented in Figure 1. The susceptible population is recruited at rate π. Among these recruited individuals, a proportion τ is educated on COVID-19 while the remaining (1 − τ) is not educated. The two susceptible classes can be infected by people from classes I 1, J, I 2, C and T, at constant rates β, ν 1 β, ν 2 β, ν 3 β and ν 4 β, respectively. Thus, the force of infection following the standard incidence is given by:

λ ( t ) = β ( I 1 ( t ) + ν 1 J ( t ) + ν 2 I 2 ( t ) + ν 3 C ( t ) + ν 4 T ( t ) ) N ( t ) .

Susceptible individuals who are educated on COVID-19 follow WHO recommendations. Their behaviours will reduce their susceptibility by a factor ξ ≔ (1 − ɛ), where ɛ measures the efficiency of protective measures (or social distancing) taken by the individuals in compartment S 1.

Figure 1: 
Flow diagram for Model (1) and for the restricted Model (2).
Figure 1:

Flow diagram for Model (1) and for the restricted Model (2).

Susceptible individuals once becoming infected arrive in compartments I 1 and I 2, depending on whether they fall in the category of educated on the virus or not, respectively. Individuals in compartment I 1 may recover at rate γ 1, decease at rate (μ + δ 1) or seek treatment through modern medicine at rate α 1. The parameter μ is the natural mortality rate while δ 1 is the mortality due to SARS-CoV-2 virus.

Patients in compartment I 2 seek traditional treatment at rate σ, recover at rate γ 2, die at rate (μ + δ 2). Some infected persons taking modern treatment combine it to traditional treatment as adjuvant (i.e. move to the class C) at rate η.

In compartment C, the death rate is (μ + δ c ) and the recovery rate is γ c . We assume that mass media disseminate information on the WHO guidelines at rate q. Meanwhile m s , m i , m c and m t measure the probability that a susceptible individual or an infected uneducated being influenced by the information received in the compartments S 2, I 2 and T. Thus due to sensitisation, m s q, m i q, m c q and m t q are the rates at which susceptible and infected individuals become aware and leave compartments S 2, I 2 and T to compartments S 1, J and C, respectively. A complete list of parameters with definitions is presented in Table 1.

Table 1:

Parameters and their epidemiological interpretations.

Parameter Epidemiological interpretation
β Effective transmission rate of COVID-19 due to contact with individuals in compartment I 1.
ν 1, ν 2, ν 3, ν 4 Modification parameters for the infectiousness of individuals in compartments J, I 2, C and T, respectively.
π Recruitment rate in the susceptible population.
τπ Proportion of susceptible individuals recruited in the compartment S 1.
α 1 Exit rate from the compartment I 1 to the compartment J.
σ Exit rate from compartment I 2 to the compartment T.
γ 1, γ 2, γ j , ω, γ c Recovery rates of infected individuals in the compartments I 1, I 2, J and T, respectively.
δ 1, δ 2, δ j , ψ, δ c Death rates due to COVID-19 in compartments I 1, I 2, J, T and C, respectively.
ɛ Efficiency of protective measures taken by susceptible individuals in compartment S 1.
q Spread rate of information in accordance with WHO guidelines.
m s Probability that an unaware susceptible individual is influenced by information and moves to S 1.
m i (m c ) Probability that an uneducated infected individual is influenced by information and moves to J (C).
m t Probability that infected who follow traditional medicine are influenced by information and move to compartment C.
η Exit rate from compartment J to the compartment C.
μ Natural mortality rate.

The model which follows is given by the ordinary differential system:

(1) S ̇ 1 ( t ) = τ π + m s q S 2 λ ( 1 ε ) S 1 μ S 1 , S ̇ 2 ( t ) = ( 1 τ ) π λ S 2 ( μ + m s q ) S 2 , I ̇ 1 ( t ) = λ ( 1 ε ) S 1 ( μ + α 1 + γ 1 + δ 1 ) I 1 , I ̇ 2 ( t ) = λ S 2 ( μ + γ 2 + δ 2 + m c q + σ + m i q ) I 2 , J ̇ ( t ) = α 1 I 1 + m i q I 2 ( μ + γ j + δ j + η ) J , T ̇ ( t ) = σ I 2 ( μ + ω + ψ + m t q ) T , C ̇ ( t ) = m c q I 2 + η J + m t q T ( μ + γ c + δ c ) C , R ̇ ( t ) = γ 1 I 1 + γ 2 I 2 + γ j J + ω T + γ c C μ R .

Nonetheless, due to evolution and development in science, controversial views as regards some diseases within some societies are gradually changing for the better. In modern societies, the belief is that diseases are exclusively due to natural causes. Education in this context will be oriented towards means of prevention and not towards the choice of a mode of treatment, since people in such a society are naturally accustomed to going to hospital facilities when they are ill. Under this assumption, Model (1) becomes:

(2) S ̇ 1 ( t ) = π λ ξ S 1 μ S 1 , I ̇ 1 ( t ) = λ ξ S 1 ( μ + α 1 + γ 1 + δ 1 ) I 1 , J ̇ ( t ) = α 1 I 1 ( μ + γ j + δ j ) J , R ̇ ( t ) = γ 1 I 1 + γ j J μ R .

For mathematical convenience, we define the following new parameters.

π 1 = τ π , π 2 = ( 1 τ ) π , ϕ j = μ + γ j + δ j + η , m 1 = m s q , m 2 = μ + m s q , ϕ 1 = μ + α 1 + γ 1 + δ 1 , m 3 = m i q , α 2 = m c q , ϕ c = μ + γ c + δ c , ξ = 1 ε , ν = m t q , ϕ t = μ + ω + ψ + ν , a j = α 1 ξ ϕ 2 π 1 + m 3 ξ ϕ 1 π 2 , b j = α 1 ξ ϕ 2 ( m 1 π 2 + m 2 π 1 ) + m 3 ϕ 1 π 2 μ , a c = ξ ϕ t ϕ j ϕ 1 α 2 π 2 + η a j ϕ t + ξ ϕ j ϕ 1 ν σ π 2 , b c = μ ϕ t ϕ j ϕ 1 α 2 π 2 + η b j ϕ t + μ ϕ j ϕ 1 ν σ π 2 k n = ( ϕ j μ + α 1 μ + γ 1 ϕ j + γ j α 1 ) , ϕ 2 = μ + γ 2 + δ 2 + m c q + σ + m i q ,

Λ = μ + δ 1 + δ 2 + δ j + ψ + δ c , a r = γ 1 ξ π 1 ϕ c ϕ t ϕ j ϕ 2 + γ j a j ϕ c ϕ t + γ c a c + μ γ 2 π 2 ϕ c ϕ t ϕ j ϕ 1 ξ , b r = γ 1 ξ ( m 1 π 2 + m 2 π 1 ) ϕ c ϕ t ϕ j ϕ 2 + μ γ 2 π 2 ϕ c ϕ t ϕ j ϕ 1 + γ j b j ϕ c ϕ t + γ c b c , a n = ξ π 2 μ ϕ c ϕ t ϕ j ϕ 1 + ξ π 1 μ ϕ c ϕ t ϕ j ϕ 2 + a j μ ϕ c ϕ t + ξ σ π 2 μ ϕ c ϕ j ϕ 1 + a c μ + a r , b n = π 1 μ ϕ c ϕ t ϕ j ϕ 2 ϕ 1 + μ 2 π 2 ϕ c ϕ t ϕ j ϕ 1 + ξ ( m 1 π 2 + m 2 π 1 ) μ ϕ c ϕ t ϕ j ϕ 2 + ξ π 2 μ ϕ c ϕ t ϕ j ϕ 2 ϕ 1 + b j μ ϕ c ϕ t + μ 2 σ π 2 ϕ c ϕ j ϕ 1 + b c μ + b r , c n = μ ϕ c ϕ t ϕ j ϕ 1 ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) , a p = β ξ π 1 μ ϕ c ϕ t ϕ j ϕ 2 + β ν 2 ξ π 1 μ ϕ c ϕ t ϕ j ϕ 1 + β ν 1 a j μ ϕ c ϕ t + β ν 3 a c μ + β ν 4 ξ σ π 2 μ ϕ c ϕ j ϕ 1 , b p = β ξ ( m 1 π 2 + m 2 π 1 ) μ ϕ c ϕ t ϕ j ϕ 2 + β ν 2 μ 2 π 2 ϕ c ϕ t ϕ j ϕ 1 + β ν 1 b j μ ϕ c ϕ t + β ν 3 b c μ + β ν 4 μ 2 σ π 2 ϕ c ϕ j ϕ 1 .

Model (1) considers the dynamics of the human population split in different compartments. Thus for biological reasons it is necessary that these variables remain positive. This is guaranteed by the following propositions, which ensure the well-posedness of Model (1) and give the biologically feasible region.

Proposition 1

For ( S 1 ( 0 ) , S 2 ( 0 ) , I 1 ( 0 ) , I 2 ( 0 ) , J ( 0 ) , T ( 0 ) , R ( 0 ) ) R 8 \ { 0 } , System (1) has a unique local solution. Moreover, if

S 1 ( 0 ) > 0 , S 2 ( 0 ) > 0 , I 1 ( 0 ) 0 , I 2 ( 0 ) 0 , J ( 0 ) 0 , T ( 0 ) 0  and  R ( 0 ) 0 ,

then

S 1 ( t ) > 0 , S 2 ( t ) > 0 , I 1 ( t ) 0 , I 2 ( t ) 0 , J ( t ) 0 , T ( t ) 0  and  R ( t ) 0 , t > 0 .

Proof

The right-hand side of System (1) is a vector valued function from R 8 into R 8 , which is continuously differentiable on R 8 \ { 0 } . Thus this function is locally Lipschitz. Consequently, by the Cauchy–Lipschitz theorem, the initial value problem for this system has a unique local solution on some interval [0, T].

Assume S 2(0) > 0 and S 1(0) > 0. By the second equation of System (1), one has,

S 2 ( t ) = S 2 ( 0 ) exp 0 t ( λ ( s ) + m 2 ) d s + exp 0 t ( λ ( s ) + m 2 ) d s × 0 t π 2 exp 0 v ( λ ( u ) + m 2 ) d u d v > 0 .

By the first equation of Model (1), one gets,

S 1 ( t ) = S 1 ( 0 ) exp 0 t ( λ ( s ) ξ + μ ) d s + exp 0 t ( λ ( s ) ξ + μ ) d s × 0 t ( π 1 + m 1 S 2 ( s ) ) exp 0 s ( λ ( u ) ξ + μ ) d u d s > 0 .

To prove the positivity of the variables I 1, I 2, J, T, C and R, we use the Tangent theorem [19]. For this, we have to show that ⟨u(y)|g(y)⟩ ≤ 0, for y on each of the hyperplanes I 1 = 0, I 2 = 0, J = 0, T = 0, C = 0 and R = 0, u being the outer normal vector to the hyperplane and g(y) is the vector field defined by the remaining equations.

For the hyperplane I 1 = 0, we have the inner product

( 1,0,0,0,0,0 ) | λ ξ S 1 , λ S 2 ϕ 2 I 2 , m 3 I 2 ϕ j , σ I 2 ϕ t T , α 2 I 2 + η J + ν T ϕ c T , γ 2 I 2 + γ j J + ω T + γ c C μ R = λ ξ S 1 0 .

Using the other hyperplanes, one can get similar results which prove that the variables I 1, I 2, T, C, J, R remain non-negative for non-negative initial conditions.□

Proposition 2

Assume

S 2 ( 0 ) π 2 m 2 , S 1 ( 0 ) π 1 m 2 + m 1 π 2 μ m 2  and  π Λ N ( 0 ) π μ .

Then

t > 0 , S 2 ( t ) π 2 m 2 , S 1 ( t ) π 1 m 2 + m 1 π 2 μ m 2  and  π Λ N ( t ) π μ .

Proof

Let us assume that S 2 ( 0 ) π 2 m 2 . By the second equation of System (1), it is straightforward that

S ̇ 2 ( t ) π 2 m 2 S 2 .

So according to the Gronwall lemma,

S 2 ( t ) π 2 m 2 + S 2 ( 0 ) π 2 m 2 e m 2 t .

That is

S 2 ( t ) π 2 m 2 t > 0 .

If one assumes in addition that S 1 ( 0 ) π 1 m 2 + m 1 π 2 μ m 2 , the application of the Gronwall lemma once more to the first equation of System (1) leads to

S 1 ( t ) π 1 m 2 + m 1 π 2 μ m 2 t > 0 .

Assume now that π Λ N ( 0 ) π μ . Adding all the equations of Model (1) gives,

N ̇ ( t ) = π μ N δ 1 I 1 δ 2 I 2 δ j J ψ T δ c C .

Therefore,

π Λ N N ̇ π μ N .

By the Gronwall lemma, one obtains

π Λ + N ( 0 ) π Λ e Λ t N ( t ) π μ + N ( 0 ) π μ e μ t .

That is

π Λ N ( t ) π μ t > 0  when  π Λ N ( 0 ) π μ .

From Propositions 1 and 2, one deduces the following result about the well-posedness of Model (1).

Proposition 3

The Model (1) is a dynamical system on the biologically feasible domain

Ω : = ( S 1 ( t ) , S 2 ( t ) , I 1 ( t ) , I 2 ( t ) , J ( t ) , T ( t ) , C ( t ) , R ( t ) ) R + 8 / S 2 ( t ) π 2 m 2 , S 1 ( t ) π 1 m 2 + m 1 π 2 μ m 2 , π Λ N ( t ) π μ .

3 Mathematical analysis of Model (1)

In order to highlight the influence of misconceptions in the dynamics of Model (1), we first analyse Model (2). The dynamics of this restricted model is summarized in the following theorem.

Theorem 1

Model (2) is a dynamical system on the feasible set

Ω 0 : = ( S 1 ( t ) , I 1 ( t ) , J ( t ) , R ( t ) ) R + 4 : π μ + δ 1 + δ j N ( t ) π μ .

Moreover, the following results holds for (2):

  1. Model (2) has a unique disease-free equilibrium (DFE) T 0 ≔ (S 0, 0, 0, 0), with S 0 = π μ , which is globally asymptotically stable (GAS) whenever R c W T 1 .

  2. Model (2) has a unique endemic equilibrium E *, which is locally asymptotically stable (LAS) when R c W T > 1 .

The proof of this theorem is presented in Appendix B. We illustrate in Figure 2 the local stability of the endemic equilibrium for Model (2) when R 0 W T > 1 . The stability of the DFE for R 0 W T < 1 will be illustrated later in numerical simulations using the estimated parameters.

Figure 2: 
Stability of the endemic equilibrium E* for 




R


c


W
T


>
1


${\mathcal{R}}_{c}^{WT}{ >}1$



.
Figure 2:

Stability of the endemic equilibrium E* for R c W T > 1 .

Figure 2 considers the value γ j  = 0.0037; δ j  = 0.0000952. The other parameters are as in Table 3. With these parameters R c W T = 2.9471 > 1 .

3.1 Determination of equilibria for Model (1)

It is straightforward to show that Model (1) has a unique equilibrium E 0 = (S 10, S 20, 0, 0, 0, 0, 0, 0), with

S 10 = m 2 π 1 + m 1 π 2 μ m 2  and  S 20 = π 2 m 2 .

Let E * = S 1 * , S 2 * , I 1 * , I 2 * , J * , T * , C * , R * be a non-frontier equilibrium for Model (1). From the set of parameters defined above, one can easily get

(3) S 2 * = π 2 λ * + m 2 , S 1 * = π λ * + m 1 π 2 + m 2 π 1 λ * + m 2 ( λ * ξ + μ ) , I 1 * = λ * ξ S 1 * ϕ 1 = ξ π 1 λ * 2 + ξ ( m 1 π 2 + m 2 π 1 ) λ * ϕ 1 λ * + m 2 ( λ * ξ + μ ) , I 2 * = λ * π 2 ϕ 2 λ * + m 2 , J * = α 1 I 1 * + m 3 I 2 * ϕ j = a j λ * 2 + b j λ * ϕ j ϕ 1 ϕ 2 λ * + m 2 ( λ * ξ + μ ) , C * = α 2 I 2 * + η J * + ν T * ϕ c = a c λ * 2 + b c λ * ϕ j ϕ c ϕ t ϕ 1 ϕ 2 λ * + m 2 ( λ * ξ + μ ) , T * = σ π 2 λ * ϕ t ϕ 2 λ * + m 2 , R * = a r λ * 2 + b r λ * μ ϕ 1 ϕ 2 ϕ j ϕ t ϕ c λ * + m 2 ( λ * ξ + μ ) , N * = S 1 * + S 2 * + I 1 * + I 2 * + J * + C * + T * + R * = a n λ * 2 + b n λ * + c n μ + ϕ c ϕ t ϕ j ϕ 1 ϕ 2 λ * + m 2 ( λ * ξ + μ ) .

Set

P * = β I 1 * + β ν 2 I 2 * + β ν 1 J * + β ν 3 C * + β ν 4 T * .

Similar computations show that

P * = a p λ * 2 + b p λ * .

Thus

λ * = P * N * = a p λ * 2 + b p λ * a n λ * 2 + b n λ * + c n .

Therefore

λ * = 0  or  a n λ * 2 + ( b n a p ) λ * + c n b p = 0 .

The value λ* = 0 leads to the frontier equilibrium. The other value of λ* verifies the equation

(4) a n c n λ * 2 + ( b n a p ) c n λ * + 1 b p c n = 0 .

Multiplying both sides of Equation (4) by c n /a n , one gets

(5) λ * 2 + ( b n a p ) a n λ * + c n a n 1 b p c n = 0 .

we note that

( b n a p ) a n = c n ( b n a p ) + a n b p a n c n b p c n .

Thus Equation (5) is equivalent to the equation

(6) λ * 2 + ( K R c ) λ * + C 1 R c = 0 ,

with

R c = b p c n , C = c n a n and  K = c n ( b n a p ) + a n b p a n c n .

The discriminant Δ ( R c ) of Equation (6) is equal to

Δ ( R c ) = R c 2 + R c ( 2 K + 4 C ) + K 2 4 C .

Set

R 1 = K 2 C 2 C ( 1 K ) + C 2  and  R 2 = K 2 C + 2 C ( 1 K ) + C 2 .

Whenever they exist, R 1 and R 2 are the roots of the equation Δ ( R c ) = 0 . According to [20], we have the following theorem:

Theorem 2

The following statements hold.

  1. Model (1) always has a unique disease-free equilibrium E 0 = (S 10, S 20, 0, 0, 0, 0, 0, 0).

  2. If R c > 1 , Model (1) has a unique positive equilibrium E*.

  3. If K > 1, Model (1) has no positive equilibrium when R c 1 . That is Equation (6) exhibits a forward bifurcation.

  4. If K 4 C then R 2 < 0 and Model (1) has two positive equilibria when R c < 1 , that is Equation (6) exhibits a full backward bifurcation.

  5. If 4 C < K < 1 then 0 < R 2 < 1 and Equation (6) exhibits backward bifurcation. That is Model (1) has:

    1. No positive equilibrium if R 0 < R 2 .

    2. One positive equilibrium if R 0 = R 2 .

    3. Two positive equilibria if R 0 ( R 2 , 1 ) .

R c is the number of secondary infections produced by an index case in a completely susceptible population, during its entire infectious period in spite of the treatments and the educational campaigns implemented.

The existence of two positive equilibria in some cases whenever the control reproduction number is less than one shows that our model may undergo a backward or a full backward bifurcation phenomenon. The existence of backward bifurcation makes the control of the disease more difficult. The requirement that R c should be less than one is no longer sufficient for the elimination of the disease. More efforts need to be made to reduce and maintain R c to a value less than R c c R 2 in order to ensure the elimination of the disease. Figure 3 shows the bifurcation diagrams produced by MATLAB. Firstly, Figure 3(a) indicates that a stable disease–free equilibrium co-exists with a stable endemic equilibrium, when R c c < R c < 1 . This supports the presence of the backward bifurcation proven. On the other hand, Figure 3(b) illustrates the case where the disease-free equilibrium loses its stability while the endemic equilibrium is stable for the values of R c greater than one. This highlights the forward bifurcation phenomenon. The presence of a full backward bifurcation shows that, in some cases, two positive equilibria may always co-exist with the DFE. In this case, the global elimination of the disease is not possible since one endemic equilibrium is always stable when R c < 1 . The bifurcation diagram exhibiting the existence of a full backward bifurcation phenomenon is given in Figure 3(c).

Figure 3: 
Bifurcation diagrams. (a) Is plotted for: μ = 10.000814; β = 0.0501; ɛ = 0.7396; τ = 100.03799; m

s
 = 0.1123; m

i
 = 0.1021; q = 0.3548; α
1 = 100000000.0277; m

c
 = 0.0238; σ = 0.068; η = 0.0327; m

t
 = 0.02208; γ
1 = 0.07571; γ
2 = 0.00000612; γ

j
 = 0.150; ω = 0.0197; γ

c
 = 0.0488; δ
1 = 0.1765; δ
2 = 0.0116; δ

j
 = 0.03608; ψ = 0.0152; δ

c
 = 0.102; π = 10.003; ν
1 = 10.000609; ν
2 = 1.4014; ν
3 = 10.7224; ν
4 = 10.9503. (b) Is plotted for: μ = 100.000814; α
1 = 0.0277; ω = 0.0000197; ν
3 = 10.7224; ν
4 = 1.9503 (the other parameters are same as in (a)). (c) Is plotted for: ɛ = 0.07396; m

s
 = 1.1123; q = 5.3548; α
1 = 10000.0277 (the other parameters same as in (a)).
Figure 3:

Bifurcation diagrams. (a) Is plotted for: μ = 10.000814; β = 0.0501; ɛ = 0.7396; τ = 100.03799; m s  = 0.1123; m i  = 0.1021; q = 0.3548; α 1 = 100000000.0277; m c  = 0.0238; σ = 0.068; η = 0.0327; m t  = 0.02208; γ 1 = 0.07571; γ 2 = 0.00000612; γ j  = 0.150; ω = 0.0197; γ c  = 0.0488; δ 1 = 0.1765; δ 2 = 0.0116; δ j  = 0.03608; ψ = 0.0152; δ c  = 0.102; π = 10.003; ν 1 = 10.000609; ν 2 = 1.4014; ν 3 = 10.7224; ν 4 = 10.9503. (b) Is plotted for: μ = 100.000814; α 1 = 0.0277; ω = 0.0000197; ν 3 = 10.7224; ν 4 = 1.9503 (the other parameters are same as in (a)). (c) Is plotted for: ɛ = 0.07396; m s  = 1.1123; q = 5.3548; α 1 = 10000.0277 (the other parameters same as in (a)).

3.2 Asymptotic stability analysis of Model (1)

Let’s define

T 1 = β ν 2 ϕ 2 + β m 3 ν 1 ϕ 2 ϕ j + β m 3 ν 3 η ϕ 2 ϕ j ϕ c + β ν 3 α 2 ϕ c ϕ 2 + β ν 4 σ ϕ 2 ϕ t + β ν ν 3 σ ϕ 2 ϕ c ϕ t

and

T 2 = β α 1 ξ ( ν 1 ϕ c + η ν 3 ) ϕ 1 ϕ j ϕ c + β α 1 ξ T 1 ( ν 1 ϕ c + ν 3 η ) ϕ 1 ϕ j ϕ c ( 1 T 1 ) + β ξ ϕ 1 ( 1 T 1 ) .

Theorem 3

If R c R 2 and T max ( T 1 , T 2 ) < 1 , then the DFE E 0 for Model (1) is globally asymptotically stable (GAS) in Ω.

Proof

Let’s consider the candidate Lyapunov function,

L = I 1 + a 2 I 2 + a 1 J + a 3 T + a 4 C ,

where a 1, a 2, a 3, a 4 are positive constants to be determined. The derivative of L is given by

L ̇ 1 = I ̇ 1 + a 2 I ̇ 2 + a 1 J ̇ + a 3 T ̇ + a 4 C ̇ β ξ ( I 1 + ν 1 J + ν 2 I 2 + ν 3 C + ν 4 T ) ϕ 1 I 1 + a 2 β ( I 1 + ν 1 J + ν 2 I 2 + ν 3 C + ν 4 T ) ϕ 2 a 2 I 2 + a 1 α 1 I 1 + a 1 m 3 I 2 a 1 ϕ j J + a 3 σ I 2 a 3 ϕ t T + a 4 α 2 I 2 + a 4 η J + a 4 ν T a 4 ϕ c C = I 1 ( ξ β ϕ 1 + a 2 β + a 1 α 1 ) + I 2 ( ξ β ν 2 + a 2 β ν 2 ϕ 2 a 2 + a 1 m 3 + a 3 σ + a 4 α 2 ) + J ( ξ β ν 1 + a 2 ν 1 β a 1 ϕ j + a 4 η ) + T ( ξ β ν 4 + a 2 β ν 4 a 3 ϕ t + a 4 ν ) + C ( ξ β ν 3 + a 2 β ν 3 a 4 ϕ c ) .

We choose the numbers a 1, a 2, a 3, a 4 such that

(7) ξ β ν 2 + a 2 β ν 2 ϕ 2 a 2 + a 1 m 3 + a 3 σ + a 4 α 2 = 0 , ξ β ν 1 + a 2 ν 1 β a 1 ϕ j + a 4 η = 0 , ξ β ν 4 + a 2 β ν 4 a 3 ϕ t + a 4 ν = 0 , ξ β ν 3 + a 2 β ν 3 a 4 ϕ c = 0 .

Simple computations show that

a 4 = β ν 3 ( ξ + a 2 ) ϕ c , a 3 = β ν 4 ( ξ + a 2 ) ϕ t + β ν 3 ν ( ξ + a 2 ) ϕ t ϕ c , a 1 = β ν 1 ( ξ + a 2 ) ϕ j + β ν 3 η ( ξ + a 2 ) ϕ c ϕ j , a 2 = ξ T 1 1 T 1 .

Since T 1 < 1 , then a 2 > 0. With these values we have

L ̇ I 1 β ξ + a 1 α 1 + β ξ T 1 1 T 1 ϕ 1 = ϕ 1 ( T 2 1 ) I 1 .

Therefore, L ̇ 0 when T 2 1 and L ̇ = 0 when T 2 = 1 or I 1 = 0. The largest invariant subset contained in the set { ( S 1 , S 2 , I 1 , I 2 , J , T , C ) Ω / L ̇ = 0 } is the DFE E 0. Thus, according to LaSalle invariance principle, E 0 is globally asymptotically stable.□

Remark 1

R c computed above can also be decomposed as

R c = R c ( 1 ) + R c ( 2 )

with

R c ( 1 ) = β ξ ( m 1 π 2 + m 2 π 1 ) ϕ 1 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ξ ν 1 α 1 ( m 1 π 2 + m 2 π 1 ) ϕ 1 ϕ j ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ξ ν 3 η α 1 ( m 1 π 2 + m 2 π 1 ) ϕ 1 ϕ c ϕ j ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) , R c ( 2 ) = β ν 1 m 3 μ π 2 ϕ j ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ν 2 μ π 2 ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ν 4 σ μ π 2 ϕ t ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ν 3 α 2 μ π 2 ϕ c ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ν 3 m 3 η μ π 2 ϕ j ϕ c ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) + β ν 3 ν σ μ π 2 ϕ c ϕ t ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) .

R c ( 1 ) (resp. R c ( 2 ) ) can be interpreted as the number of secondary cases one educated (resp. uneducated) infected introduced into a completely susceptible population could produce. It can be seen that

R c ( 2 ) = T 1 μ π 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) ,  that is,  R c ( 2 ) < T 1 .

Similarly, it is evident that R c ( 1 ) < T 2 . With these comparisons, it follows that when T 1 , an infected introduced in the population will generate less than one case within the educated population and less than one case within the uneducated population.

The next result summarizes the behaviour of Model (1), whenever R c is greater, but close to one.

Theorem 4

The unique endemic equilibrium for Model (1) is locally asymptotically stable (LAS) if R c > 1 , and for values of R c close to one. In addition, System (1) undergoes a trans-critical bifurcation with R c = 1 being the bifurcation parameter.

The Proof of Theorem 4 is presented in Appendix C.

Figure 4 illustrates the stability of the endemic equilibrium for R c > 1 and suggests the global asymptotic stability of the endemic equilibrium. The stability of the endemic equilibrium established in Theorem 4, whenever the control reproduction number is greater than unity calls for the implementation of control measures which can have significant impact on the dynamics of COVID-19.

Figure 4: 
Stability of the endemic equilibrium for 




R


c


>
1


${\mathcal{R}}_{c}{ >}1$



. Figure 4 considers the values γ
1 = 0.01538; γ
2 = 0.04021; γ

j
 = 0.00102; ω = 0.01; γ

c
 = 0.0001. The other parameters are as in Table 3. With these parameters 




R


c


=
2.8312


${\mathcal{R}}_{c}=2.8312$



.
Figure 4:

Stability of the endemic equilibrium for R c > 1 . Figure 4 considers the values γ 1 = 0.01538; γ 2 = 0.04021; γ j  = 0.00102; ω = 0.01; γ c  = 0.0001. The other parameters are as in Table 3. With these parameters R c = 2.8312 .

4 Model calibration and validation

Model (2) and Model (1) are calibrated using the daily cumulative cases of COVID-19 reported in South Africa from January to February 2022 (59 days), as given in [21]. The choice of South Africa is motivated by the free availability of data and the fact that herbal remedies is widely used to treat different pathologies like the COVID-19 in this country as indicated by some studies [5], [8]. The data are fitted using the nonlinear least squares algorithm implemented by fminsearcbnd function in MATLAB. This function is advantageous over fminsearch in that the fitted parameters are kept in their range [22].

According to [23], the population of South Africa is 60,576,141. On January 1st, 2022 there were 3,468,079 cumulative number of COVID-19 cases in this country, with 3,182,969 recovered and 91,198 deaths. This means that as of this date, it were exactly 193,912 active COVID-19 cases in South Africa. In the calibration process, this number of active cases is partitioned equally into the infected cases of compartments I 1 and J, for Model (2) and the infected cases in compartments I 1, I 2, J, T and C, for Model (1). The initial conditions are clearly indicated in Table 2.

Table 2:

Initial calibration conditions for simulations.

Variable at t = 0 Value (Model (1)) Value (Model (2))
S 1(0) 28,554,031 57,108,062
S 2(0) 28,554,031
I 1(0) 38,783 96,956
I 2(0) 38,783
J(0) 38,782 96,956
T(0) 38,782
C(0) 38,782
R(0) 3,182,969 3,182,969

The fitting curves for Model (2) and Model (1) with the parameters in Table 3 and the curves from real data are shown in Figure 5(a) and (b). The values of the control reproduction number with the estimated parameters are displayed in Table 4. The values are less than one, indicating that the disease will die out, at least locally. The solutions of the models plotted with different initial conditions in Figure 5(c) (for Model (2)) and Figure 5(d) (for Model (1)) support this result.

Table 3:

Estimated parameters and assumed range of values for simulation of Model (2) and Model (1).

Parameter Range Estimated value Estimated value Source
Model (1) Model (2)
ɛ 0–1 0.0592 0.8161 Fitted
τ 0–1 0.7101 Fitted
m s 0–1 0.0258 Fitted
m i 0–1 0.152 Fitted
m c 0–1 0.0022 Fitted
m t 0–1 0.1276 Fitted
β 0–1 0.0507 0.2798 Fitted
q 0–1000 0.6476 Fitted
α 1 0–1 0.1059 0.1044 Fitted
η 0–1 0.0995 Fitted
σ 0–1 0.0505 Fitted
μ 0–1 0.0003516 0.0003516 [24]
δ 1 0–1 0.015 0.0650 Fitted
δ 2 0–1 0.01 Fitted
δ j 0–1 0.0104 0.0952 Fitted
ψ 0–1 0.0025 Fitted
δ c 0–1 0.002 Fitted
π 0–1000 50.00 100.0879 Fitted
ν 1 0–1 0.2171 0.4125 Fitted
ν 2 0–2 1.4016 Fitted
ν 3 0–2 1.3503 Fitted
ν 4 0–2 1.9069 Fitted
γ 1 0–1 0.1538 0.0291 Fitted
γ 2 0–1 0.421 Fitted
γ c 0–1 0.0522 Fitted
γ j 0–1 0.0102 0.0370 Fitted
ω 0–1 0.299 Fitted
Figure 5: 
(a) and (b) – Real data and fitted curves: Jan–Feb 2022 for Model (2) and Model (1). (c) and (d) – Long term behaviour of the solutions for Model (2) and Model (1).
Figure 5:

(a) and (b) – Real data and fitted curves: Jan–Feb 2022 for Model (2) and Model (1). (c) and (d) – Long term behaviour of the solutions for Model (2) and Model (1).

Table 4:

Estimated fitting metrics and control reproduction numbers for Models (2) and (1).

Threshold/metric Model (2) Model (1)
R c ( 2 ) 0.378 (65.08 % de R c )
R c ( 1 ) 0.2054 (34.92 % de R c )
R c W T , R c 0.3435 0.5808
MAE 7.3113 2.4186
RMSE 56.1591 18.5778

Model calibration assessment based on root-mean-squared error (RMSE) and mean absolute error (MAE) is often used to evaluate the goodness of our calibration. Multiple metrics is a requirement if we want to have a complete picture of error distribution. We use MAE and RMSE to assess the model performance. They are given by,

M A E = 1 N p i = 1 N p | e i |  and  R M S E = 1 N p i = 1 N p e i 2 1 / 2 ,

where Y(i) = original cases, Y ̂ ( i )  = predicted values, N p  = data size and e i = Y ( i ) Y ̂ ( i ) . The estimated values for MAE and RMSE obtained from the fitting of Model (2) and Model (1) are given in Table 4. The low values of these metrics show that both models can be used to understand and describe the dynamics of COVID-19 in South Africa. However, Table 4 points out that the fitting of Model (1) is better than the fitting of Model (2) (since values of the MAE and RMSE for the former model are less than those of the latter). This highlights that misconceptions and traditional medicine should be taken into account in order to accurately describe the dynamics of the disease in South Africa. Therefore the parameters obtained for the fitting of Model (1) are more close to the reality and will be used in the sequel of this work.

The parameter values obtained from System (1) indicate that the population does not greatly adhere to the sensitization campaigns. Infected people in compartment I 2 are more influenced by the information campaigns than susceptible individuals and those in compartment T. Furthermore, the fitting show that traditional medicine followed by the combination of the two modes of treatment lead to a greater recovery rate than modern medicine taken exclusively. Death rate in hospital is greater than the disease-induced mortality in compartments T and C. This is probably due to the fact that critical and COVID-19 cases with respiratory problems are generally follow-up in hospitals. The death rate in this category of patients is usually high. Values for estimated parameters representing the transmission rates of the disease are very high in infected individuals in compartments I 2, T and C. This is an indication of non-observance and non–respect of preventive measures of people in this group.

In Figure 6, we plot the dynamics of the infected individuals under treatment with the estimated values. The graphs point out that the population prefers the combination of the two modes of treatment instead of either modern or traditional medicine alone. This is a clear indication that traditional medicine, taken as adjuvant has its place in the control of the COVID-19. Moreover, this Figure shows that as time evolves, the recourse to traditional medicine alone phases out probably due to sensitisation campaigns. It is therefore useful to question if this fact is favourable to the control of the disease or not.

Figure 6: 
Number of infected cases following each mode of treatment.
Figure 6:

Number of infected cases following each mode of treatment.

5 Impact of educational campaigns and behavioural change

Media campaigns and different modes of treatment have been used to reduce the spread of COVID-19 and to facilitate case management [2]. The media campaigns had two main objectives: (a) raise awareness on the modes of transmission of the disease and (b) fight against misconceptions about the disease. In this section, we investigate the impact of media campaign objectives and the influence of the rate of dissemination of messages on the dynamics of the disease.

5.1 Importance of preventive measures driven by media

The media campaign objective (a) influences the parameter ɛ, which varies between 0 and 1. If its value is large, then it is an indication that more people adhere to prevention measures. We see in Figure 7 that, when ɛ increases, the number of infected people decreases as well. This implies that, increasing the value of the parameter ɛ would have a favourable impact on the dynamics of COVID-19. This result, which justifies the importance of education campaigns was predictable to say the least. The gap between the curves plotted at the end-time of the simulations are given in Table 5.

Figure 7: 
Sensitivity of ɛ: ɛ = 0.0592 (solid curve); ɛ = 0.2 (dash curve).
Figure 7:

Sensitivity of ɛ: ɛ = 0.0592 (solid curve); ɛ = 0.2 (dash curve).

Table 5:

Number of infected at the end-time of simulations.

Efficiency of protective measures Infected in J Infected in C Infected in T Cumulative cases
ɛ = 0.0592 0.6 × 104 1.9 × 104 0 3.67 × 106
ɛ = 0.2 0.5 × 104 1.8 × 104 0 3.64 × 106

5.2 Influence of sensitization campaigns towards conventional medicine

Objective (b) of education campaigns is controversial, since the focus was to orient infected unaware to modern treatment facilities. We want to investigate what would have happened if messages disseminated did not influence the infected unaware individuals. In this case, people who required treatment in compartment I 2 because they did not believe in the existence of the disease, will be followed by traditional practitioners. That is, the transitions m i q and m c q from compartment I 2 to the compartments J and C will take place in the compartment T, and the transition parameter m t from T to C will be zero. The dynamics of the infected individuals people on treatment becomes:

(8) J ̇ ( t ) = α 1 I 1 ( μ + γ j + δ j + η ) J , T ̇ ( t ) = σ I 2 + m c q I 2 + m i q I 2 ( μ + ω + ψ ) T , C ̇ ( t ) = η J ( μ + γ c + δ c ) C .

To illustrate the influence of the objective (b), we plot the curves of the infected under treatment when media orient people towards modern medicine and the curve when the infected under treatment follow the dynamics of the System (8). The output is presented in Figure 8. This figure shows that, the number of infected in compartments J and C would have decreased while those in T would have increased if the infected were not influenced by media to go to hospital. Furthermore, the cumulative number of infected cases would have decreased. This reveals that the media’s objective (b) of directing people to modern treatment methods was detrimental to the control of the disease by increasing the number of cases. The gap between the curves plotted at the end-time of simulations is provided in Table 6.

Figure 8: 
Influence of sensitization campaigns in favour of conventional medicine. This Figure is plotted for two cases. (a) Media campaigns biased towards modern medicine; (b) media campaigns not biased towards any treatment mode.
Figure 8:

Influence of sensitization campaigns in favour of conventional medicine. This Figure is plotted for two cases. (a) Media campaigns biased towards modern medicine; (b) media campaigns not biased towards any treatment mode.

Table 6:

Number of infected at the end-time of simulations.

Scenario Infected in J Infected in C Infected in T Cumulative cases
When media orient towards modern medicine 0.6 × 104 2 × 104 0 3.66 × 106
When media did not orient towards modern medicine 0.3 × 104 1.4 × 104 0 3.64 × 106

5.3 Influence of spreading rate of messages q

During the peak of the COVID-19 pandemic, media attention worldwide was on the pathology, preventive measures and treatment of the disease. Did this strong media interest have a positive impact on the disease dynamics? We answer this question by varying the parameter q of the spread of information about COVID-19. We consider the three scenarios: (i) q = 0.6476; ɛ = 0.0592, (ii) q = 0.3; ɛ = 0.0592 and (iii) q = 0, ɛ = 0. Figure 9 shows that when q decreases from 0.6476 to 0, the number of infected in compartment T increases, but those in compartments J and C as well as the cumulative number of infected cases decrease. This figure highlights that a high level of media coverage did not have a favourable impact on the dynamics of the disease. The difference between the curves at the end-time of simulations is provided in Table 7.

Figure 9: 
Sensitivity of q.
Figure 9:

Sensitivity of q.

Table 7:

Number of infected at the end-time of simulations.

Scenario Infected in J Infected in C Infected in T Cumulative cases
q = 0.6476; ɛ = 0.0592 0.75 × 104 0 2 × 104 3.68 × 106
q = 0.3; ɛ = 0.0592 0.5 × 104 0 1.6 × 104 3.65 × 106
q = 0; ɛ = 0 0.25 × 104 0 1.3 × 104 3.63 × 106

5.4 Media awareness campaigns with no herbal remedies

Suppose that the population is assumed to believe in modern medicine only and education campaigns only buttress their conviction in modern treatment and to follow preventive measures. Under this hypothesis, unaware infected individuals in I 2 will either seek only modern treatment or recover naturally. That is m c  = σ = m t  = η = 0 (m i q is defined here as the individuals in I 2 who need treatment). The Model (1) becomes:

(9) S ̇ 1 ( t ) = τ π + m s q S 2 λ ( 1 ε ) S 1 μ S 1 , S ̇ 2 ( t ) = ( 1 τ ) π λ S 2 ( μ + m s q ) S 2 , I ̇ 1 ( t ) = λ ( 1 ε ) S 1 ( μ + α 1 + γ 1 + δ 1 ) I 1 , I ̇ 2 ( t ) = λ S 2 ( μ + γ 2 + δ 2 + σ + m i q ) I 2 , J ̇ ( t ) = α 1 I 1 + m i q I 2 ( μ + γ j + δ j ) J , R ̇ ( t ) = γ 1 I 1 + γ 2 I 2 + γ j J μ R .

We plot the dynamics of infected in J and the cumulative number of infected for Systems (1) and (9). The output is shown in Figure 10. This figure shows that the number of patients in the hospital would explode, but the number of cumulative cases would decrease. This figure underscores the place of modern medicine in the fight against COVID-19.

Figure 10: 
Media campaigns in the absence of traditional practitioners.
Figure 10:

Media campaigns in the absence of traditional practitioners.

5.5 Impact of delaying awareness on the dynamics of COVID-19

To fight against COVID-19, the media outlets convey messages to raise awareness in the population. However, there is no guarantee that the population adheres to these messages. Educational campaigns messages could sometimes have impact not on all but only on some compartments of infected individuals. Therefore there is a delay in the assimilation of information by the entire population. Having this in mind, we assume the following scenario on delaying awareness in educational campaigns:

  1. Short delay: only susceptible individuals are not influenced by the media i.e. m s  = 0 (in this case, all the infected uneducated are influenced by media);

  2. Long delay: susceptible individuals as well as infected individuals in the compartment I 2 do not get or are refractory to disseminated messages i.e. m s  = m i  = m c  = 0 (only people in T are influenced by media);

  3. Infinite delay: all uneducated individuals do not get or are refractory: m s  = m i  = m c  = m t  = 0.

The results are provided in Figure 11. This figure suggests that the non-adherence of the population to disseminated messages in order to transit from uneducated compartment to the educated one, unexpectedly has a favourable impact on the dynamics of COVID-19 in reducing the disease burden. This impact is particularly more pronounced in the infected cases in compartment C and in the cumulative number of infected (the cases (ii) and (iii) are merged in J, while the cases (i) and (ii) are merged in T). This is an indication that traditional medicine has a prominent role in the treatment and management of COVID-19 and highlights that, educational campaigns have to be focused on preventive measures only. The difference between the curves constructed at the end-time of simulations is provided in Table 8.

Figure 11: 
Impact of delaying awareness.
Figure 11:

Impact of delaying awareness.

Table 8:

Number of infected at the end-time of simulations.

Scenario Infected in J Infected in C Infected in T Cumulative cases
m s  = 0 0.4 × 104 2 × 104 0 3.67 × 106
m s  = m i  = m c  = 0 0.2 × 104 1.3 × 104 0 3.65 × 106
m s  = m i  = m c  = m t  = 0 0.2 × 104 1.2 × 104 0 3.645 × 106

6 Global sensitivity analysis

Obtaining reliable results and useful information requires performing crucial phases in the model-building process such as: parameter identification, model calibration and the quantification of uncertainty. The sensitivity analysis of the model can be performed either through the normalized forward sensitivity index (NFSI) or the computation of the partial rank correlation coefficients (PRCC) of the model parameters. Contrarily to the NFSI, the PRCC method is more suitable because it allows you to obtain the sensitivity of each parameter when all the parameters are changing. This sensitivity is known as the global sensitivity analysis (GSA). The GSA is useful in identifying influential parameters of the model i.e. the parameters which have great impact on the dynamics of the disease. For GSA, we focus on the impact of model parameter variations on the total infected population (I 1 + I 2 + J + T + C). We assume that each parameter is a random variable having values within the ranges and baseline values displayed in Table 3.

We employ the Latin hypercube sampling (LHS) which is a statistical method for generating a near-random sample of parameter values from a multidimensional distribution. In our design the LHS scheme samples 1000 values for each input parameter from a uniform distribution. The partial rank correlation coefficients (PRCC) and the corresponding p-values (are computed in MATLAB) for the total number of infected are presented in the form of a histogram in Figure 12. A reader interested in understanding global sensitivity analysis should see [25].

Figure 12: 
PRCCs of (I
1 + I
2 + J + T + C).
Figure 12:

PRCCs of (I 1 + I 2 + J + T + C).

In the analysis, parameters with large PRCC values ( > 0.05 or < 0.05 ) as well as corresponding small p-values ( < 0.05 ) are the most important [26]. The closer the PRCC value is to +1 or −1, the more strongly the LHS parameter influences the outcome measure. From Figure 12, the parameter β is seen to be the most sensitive which contributes to an increase in the number of infected cases. The parameters δ 1, ω, μ, γ 1, γ c , ψ, γ 2, γ j , δ 2 , δ c and δ j in this order are the most influential parameters which contribute in decreasing the number of infected whenever they increase. This analysis points out that the recovery rate ω is more sensitive than γ j and γ c . This supports that, traditional medicine has a prominent role to play in the control of the disease. However, the impacts of the probabilities m c , m t , m s , m i that uneducated individuals are influenced by information as well as the rate of spread of messages q are mixed (some of these parameters have a favourable impact and other a negative impact). This proves that the impact of media campaigns is not always favourable in the control of COVID-19.

The sensitivity analysis results also highlight the importance of preventive measures on the dynamics of the disease. But this impact is less sensitive than the recovery rates. Thus, the scientific community (modern and traditional doctors) has a duty to develop more efficient treatment protocols for COVID-19 patients in order to increase the values of the parameters γ c , γ j and ω.

7 Discussion

We have proposed a two-group model which assesses the impact of traditional and modern medicine in curbing the spread of COVID-19 using data from South Africa. In the conception of the model, we have introduced parameters which measure and capture among others the impact of sensitization campaigns. We have deliberately been biased against traditional medicine in order to better appreciate its place in the control and management of COVID-19.

The proposed model focused on the two modes of treatment as well as a blend of the two. Susceptible and infected individuals had the free choice between modern medicine and traditional medicine. The only constraint is that they could not switch treatments but could complement with the other if they chose to. From the mathematical analysis stand point, the postulated model has a disease-free equilibrium, it is globally asymptotically stable in some cases when the computed threshold T is less than one and exhibits the phenomenon of backward bifurcation. When the control reproduction number R c is greater than one, the model has a unique endemic equilibrium. The effective reproduction number obtained is R c = 0.5808 , which indicates that the COVID-19 virus is likely to fade away, at least locally.

Numerical simulations confirm the usefulness of preventive measures in reducing the number of infected cases. However, the objective of persuading people to seek modern treatment could be detrimental to the control of the disease. The simulation results also show that delay in awareness of the population is favourable for the control of the disease. Calibration of the model has shown that infected individuals are the ones more influenced by the WHO campaign messages than the susceptible individuals.

Despite ongoing debates and controversies surrounding the use of traditional medicine in the prevention and management of the COVID-19, patients in many African countries continue to seek remedy from it. Our results showed a preference for the combination of modern medicine with traditional medicine instead of one medicine as a stand-alone therapy. Therefore, traditional medicine and modern medicine should complement each other if we are to gain the fight against COVID-19. More elaborate mathematical models that incorporate other components such as vaccination will help enlighten stakeholders and practitioners in modern and traditional medicines.

There are limited studies and clinical trials on the effectiveness of traditional medicine in the prevention and treatment of COVID-19. However, results from mathematical models such as the one presented may give an insight into the future of traditional medicine in COVID-19 treatment or in the treatment of other infectious diseases.


Corresponding author: Arsène Jaurès Ouemba Tassé, School of Computer Science and Applied Mathematics, University of the Witwatersrand Johannesburg, Johannesburg, South Africa; and Mony Keng Higher Institute, Bafoussam, Cameroon, E-mail:

Acknowledgement

We heartily thank the anonymous reviewers for their useful comments and suggestions.

  1. Research ethics: Not applicable.

  2. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. The authors contributed equally to this manuscript.

  3. Competing interests: The authors state no conflict of interest.

  4. Research funding: None declared.

  5. Data availability: The data is accessible via the link: https://sacoronavirus.co.za/ Accessed: Apr. 4, 2022.

Appendix A: Notations and abbreviations

In this Appendix, we present all abbreviations used and their definitions (Table 9).

Table 9:

Notations and abbreviations.

Abbreviation Description
COVID-19 Novel Coronavirus 2.
DFE Disease-free equilibrium.
WHO The World Health Organization.
LAS Locally asymptotically stable.
GAS Globally asymptotically stable.
S 1(t) Susceptible individuals who believe in the natural existence of the COVID-19 and trust that modern medicine is the right choice against the disease.
S 2(t) Susceptible individuals who: (a) mistake COVID-19 for influenza; (b) link the disease to witchcraft or other causes; (c) deny the existence of Sars-CoV-2 virus; (d) believe in traditional medicine for the treatment of the disease.
I 1(t) Infected individuals who were formerly in compartment S 1 and not receiving any treatment actually.
I 2(t) Infected individuals who were formerly in compartment S 2 and not receiving any treatment actually.
J(t) Infected individuals receiving modern medicine treatment only, following the protocol recommended by the WHO.
T(t) Infected individuals receiving traditional medicine only.
C(t) Infected individuals who combine modern medicine and traditional medicine.
R(t) Recovered individuals.
R c W T Control reproduction number of Model (2).
R c Control reproduction number of Model (1).
MAE Mean Absolute Error.
RMSE Root-mean-squared error.

Appendix B: Proof of Theorem (1)

For Model (1), one has N = S 1 + I 1 + J + R, λ = β ( I 1 + ν 1 J ) N and ϕ j  = μ + γ j  + δ j . Setting the right hand side of Model (2) equal to 0 in order to determine the equilibria of our restrictive model gives for any equilibrium E * = (S 1*, I 1*, J *, R *):

S 1 * = π μ + λ * ξ , I 1 * = λ * ξ S 1 * ϕ 1 , J * = α 1 λ * ξ S 1 * ϕ 1 ϕ j , R * = γ 1 λ * ξ S 1 * μ ϕ 1 + γ j α 1 λ * ξ S 1 * μ ϕ j ϕ 1 , N * = S 1 * ( μ ϕ 1 ϕ j + λ * ξ ( ϕ j μ + α 1 μ + γ 1 ϕ j + γ j α 1 ) ) μ ϕ 1 ϕ j .

Straightforward computations give

λ * = 0  or  λ * = μ ϕ 1 ϕ j ξ ( ϕ j μ + α 1 μ + γ 1 ϕ j + γ j α 1 ) R c W T 1 ,  with  R c W T = β ξ ( ϕ j + ν 1 α 1 ) ϕ 1 ϕ j .

Thus, the restricted Model (2) has the trivial equilibrium T 0 = (S 0, 0, 0, 0) (with S 0 = π μ ) and a positive equilibrium E * = (S 1*, I 1*, J *, R *), which exists if and only if R c W T > 1 , with R c W T the control reproduction number for Model (2).

We want now to prove the global asymptotic stability of the DFE for Model (2). For that, let us consider the candidate Lyapunov function

L = I 1 + a J ,

where a is a positive number to be determined. By simple computations, one has

L ̇ β ξ ( I 1 + ν 1 J ) ϕ 1 I 1 + a α 1 I 1 a ϕ j J = I 1 ( β ξ ϕ 1 + a α 1 ) + J ( β ξ ν 1 a ϕ j ) .

We choose a such that βξν 1 −  j  = 0 i.e. a = β ξ ν 1 ϕ j . This expression in the inequality above gives

L ̇ ϕ 1 R c W T 1 I 1 .

Thus, L ̇ 0 and L ̇ = 0 if and only if I 1 = 0 or R c W T = 1 . The largest invariant subset contained in the set { ( S 1 , I 1 , J , R ) / L ̇ = 0 } is the unique point T 0. Consequently, by LaSalle invariance principle [27], T 0 is GAS.

It remains to prove the local asymptotic stability of E * when R c W T > 1 . The Jacobian matrix J * of Model (2) at the equilibrium E * is

J * = μ λ * ξ 1 S 1 * N * ξ β S 1 * N * + ξ λ * S 1 * N * ξ β ν 1 S 1 * N * + ξ λ * S 1 * N * ξ λ * S 1 * N * λ * ξ 1 S 1 * N * ξ β S 1 * N * ξ λ * S 1 * N * ϕ 1 ξ β ν 1 S 1 * N * ξ λ * S 1 * N * ξ λ * S 1 * N * 0 α 1 ϕ j 0 0 γ 1 γ j μ

Considering the row 1 of matrix J * as a pivot row and computing R 2 ← R 2 + R 1, one gets the matrix

J 1 1 = μ λ * ξ 1 S 1 * N * ξ β S 1 * N * + ξ λ * S 1 * N * ξ β ν 1 S 1 * N * + ξ λ * S 1 * N * ξ λ * S 1 * N * μ ϕ 1 0 0 0 α 1 ϕ j 0 0 γ 1 γ j μ

Similarly, by considering the column 1 of matrix J 1 1 as a pivot column and computing C 2 ← C 2 + C 1, one gets the matrix

J 1 = μ λ * ξ 1 S 1 * N * μ λ * ξ 1 S 1 * N * ξ β S 1 * N * + ξ λ * S 1 * N * ξ β ν 1 S 1 * N * + ξ λ * S 1 * N * ξ λ * S 1 * N * μ ϕ 1 μ 0 0 0 α 1 ϕ j 0 0 γ 1 γ j μ

The matrices J * and J 1 have the same eigenvalues. We make also successively the computations R 1 N * ξ λ * S 1 * μ R 1 + R 4 and C 1 N * ξ λ * S 1 * μ C 1 + C 4 , one gets respectively the matrices

J 2 1 = μ 2 N * ξ λ * S 1 * μ λ * ξ N * ξ λ * S 1 * + μ 2 μ μ 2 N * ξ λ * S 1 * μ N * λ * ξ ξ λ * S 1 * μ β λ * + γ 1 ξ β ν 1 μ λ * ξ + μ + γ j 0 μ ϕ 1 μ 0 0 0 α 1 ϕ j 0 0 γ 1 γ j μ

J 2 = N * μ λ * ξ S 1 * μ 2 N * ξ λ * S 1 * μ λ * ξ N * ξ λ * S 1 * + μ 2 μ μ 2 N * ξ λ * S 1 * μ N * λ * ξ λ * S 1 * μ β λ * + γ 1 ξ β ν 1 μ λ * + μ 0 N * μ 2 λ * ξ S 1 * ϕ 1 μ 0 0 0 α 1 ϕ j 0 μ γ 1 γ j μ

J 2 and J * have the same eigenvalues. Clearly −μ is an eigenvalue of J *. The other eigenvalues of J * are those of the matrix

J 3 = N * μ λ * ξ S 1 * μ 2 N * ξ λ * S 1 * μ λ * ξ N * ξ λ * S 1 * + μ 2 μ μ 2 N * ξ λ * S 1 * μ N * λ * ξ λ * S 1 * μ β λ * + γ 1 ξ β ν 1 μ λ * + μ N * μ 2 λ * ξ S 1 * ϕ 1 μ 0 0 α 1 ϕ j = : ( m i j ) ,

with

m 11 = N * μ λ * ξ S 1 * μ 2 N * ξ λ * S 1 * μ λ * ξ N * ξ λ * S 1 * + μ , m 12 = 2 μ μ 2 N * ξ λ * S 1 * μ N * λ * ξ λ * S 1 * μ β λ * + γ 1 , m 13 = ξ β ν 1 μ λ * + μ , m 21 = N * μ 2 λ * ξ S 1 * , m 22 = ϕ 1 μ , m 23 = 0 , m 31 = 0 , m 32 = α 1 , m 33 = ϕ j .

The eigenvalues of J 3 using MAPPLE are computed and they are given by

λ 1 = m 11 , λ 2 = ( m 11 m 22 + m 21 m 12 ) m 11 = λ 2 m 11 ,  with  λ 2 = m 11 m 22 + m 21 m 12 λ 3 = m 11 m 22 m 33 + m 11 m 32 m 23 + m 33 m 21 m 12 + m 22 m 31 m 13 ( m 11 m 22 + m 21 m 12 ) = m 33 λ 2 λ 2 = m 33 = ϕ j < 0 λ 1 = N * μ λ * ξ S 1 * μ 2 N * ξ λ * S * + μ 1 N * S 1 * < 0

It remains to show that λ 2 is negative.

λ 2 = N * μ λ * ξ S 1 * 2 μ 2 + μ 3 N * λ * ξ S 1 * + μ 2 N * S 1 * + μ 2 β λ * μ γ 1 + ( ϕ 1 + μ ) μ 1 N * S 1 * μ 2 N * λ * ξ S 1 * = N * μ λ * ξ S 1 * ϕ 1 μ 1 N * S 1 * μ 2 N * λ * ξ S 1 * μ 2 + μ 2 β λ * μ γ 1 .

On the other hand, one has

μ 2 β λ * μ 2 N * ϕ 1 ξ λ * S 1 * = μ β ξ k n ϕ j ϕ 1 R 0 W T 1 k n ϕ 1 μ ϕ j + ϕ j ϕ 1 μ R 0 W T 1 ϕ j 2 ϕ 1 R 0 W T 1 = μ k n ϕ j R 0 W T 1 β ξ ϕ 1 1 R 0 W T 1 = μ k n ϕ j R 0 W T 1 β ξ ν 1 α 1 ϕ 1 ϕ j < 0

and so λ 2 < 0 . Therefore, all the roots of the matrix J * are negative for R 0 W T > 1 and the local asymptotic stability of E * follows.

Appendix C: Proof of Theorem (4)

Assume R c > 1 . We choose β as the bifurcation parameter for Model (1). The critical value β* of β at R c = 1 is given by:

β * = μ ϕ c ϕ t ϕ j ϕ 1 ϕ 2 ( μ π 2 + ( m 1 π 2 + m 2 π 1 ) ) ξ ( m 1 π 2 + m 2 π 1 ) μ ϕ c ϕ t ϕ j ϕ 2 + ν 2 μ 2 π 2 ϕ c ϕ t ϕ j ϕ 1 + ν 1 b j μ ϕ c ϕ t + ν 3 b c μ + ν 4 μ 2 σ π 2 ϕ c ϕ j ϕ 1 .

In order to investigate the stability of the endemic equilibrium for System (1), we order the variables of Model (1) as (S 1, S 2, I 1, I 2, J, T, C, R). The Jacobian matrix J for the System (1) at the DFE E 0 when β = β* has zero as a simple eigenvalue [28] (with all other eigenvalues having negative real parts). Thus, the center manifold theory can be used to prove the local asymptotic stability of the endemic equilibrium of System (1) near the bifurcation parameter β = β*.

One can show that the components of a right-eigenvector p = ( p 1 , p 2 , p 3 , p 4 , p 5 , p 6 , p 7 , p 8 ) T and a left-eigenvector u = ( u 1 , u 2 , u 3 , u 4 , u 5 , u 6 , u 7 , u 8 ) T of J associated with the zero eigenvalue are given by the following two systems:

p 3 , p 4 > 0 , p 6 = σ p 4 ϕ t , p 5 = α 1 p 3 + m 3 p 4 ϕ j , p 7 = ( α 2 ϕ j ϕ t + η m 3 ϕ t + ν σ ϕ j ) p 4 + η α 1 ϕ t p 3 ϕ j ϕ c ϕ t , p 8 = ( γ 1 ϕ j ϕ c ϕ t + γ j α 1 ϕ c ϕ t + γ c η α 1 ϕ t ) p 3 μ ϕ j ϕ c ϕ t + ( γ 2 ϕ j ϕ t + γ j m 3 ϕ t + ω σ ϕ j ) p 4 ϕ t ϕ j μ , p 2 = β * S 20 m 2 N 0 ϕ j ϕ c ϕ t ( ϕ j ϕ c ϕ t + ν 1 α 1 ϕ c ϕ t + ν 3 η α 1 ϕ t ) p 3 + ν 2 ϕ j ϕ t ϕ c + ν 1 m 3 ϕ t ϕ c + ν 4 σ ϕ j ϕ c + ν 3 ( α 2 ϕ j ϕ t + η m 3 ϕ t + ν σ ϕ j ) , p 1 = β * ξ S 10 μ N 0 ϕ j ϕ c ϕ t ( ϕ j ϕ c ϕ t + ν 1 α 1 ϕ c ϕ t + ν 3 η α 1 ϕ t ) p 3 + ν 2 ϕ j ϕ t ϕ c + ν 1 m 3 ϕ t ϕ c + ν 4 σ ϕ j ϕ c + ν 3 ( α 2 ϕ j ϕ t + η m 3 ϕ t + ν σ ϕ j ) .

and

u 1 = u 2 = u 8 = 0 , u 3 , u 4 > 0 , u 7 = β * ν 3 N 0 ϕ c ( ξ S 10 u 3 + S 20 u 4 ) u 6 = β * ϕ c ϕ t N 0 [ ( ϕ c ν 4 + ν ν 3 ) ξ S 10 u 3 + ( ϕ c ν 4 + ν ν 3 ) S 20 u 4 ] , u 5 = β * N 0 ϕ j [ ( ϕ c ν 1 + η ν 3 ) ξ S 10 u 3 + ( ϕ c ν 1 + η ν 3 ) S 20 u 4 ]

Following [28], [29], we set

a = k , i , j = 1 8 u k p i p j 2 f k x i x j ( 0,0 ) and b = k , i = 1 8 u k p i 2 f k x i β * ( 0,0 ) .

Simple computations show that,

a = 2 u 3 ξ β * N 0 1 1 S 10 N 0 ( p 1 p 3 + ν 2 p 1 p 4 + ν 1 p 1 p 5 + ν 4 p 1 p 6 + ν 3 p 1 p 7 ) β * N 0 2 S 10 ( p 3 2 + ( 1 + ν 2 ) p 3 p 4 + ( 1 + ν 1 ) p 3 p 5 + ( 1 + ν 4 ) p 3 p 6 + ( 1 + ν 3 ) p 3 p 7 + p 4 p 8 + ν 2 p 4 2 + ( ν 1 + ν 2 ) p 4 p 5 + ( ν 2 + ν 4 ) p 4 p 6 + ( ν 2 + ν 3 ) p 4 p 7 + ν 2 p 4 p 8 + ( ν 1 + ν 4 ) p 5 p 6 + ( ν 1 + ν 3 ) p 5 p 7 + ν 1 p 5 p 8 + ( ν 3 + ν 4 ) p 6 p 7 + ν 4 p 6 p 8 + ν 3 p 7 p 8 2 u 4 β * N 0 1 1 S 20 N 0 ( p 2 p 3 + ν 2 p 2 p 4 + ν 1 p 2 p 5 + ν 4 p 2 p 6 + ν 3 p 2 p 7 ) β * N 0 2 S 20 ( p 3 2 + ( 1 + ν 2 ) p 3 p 4 + ( 1 + ν 1 ) p 3 p 5 + ( 1 + ν 4 ) p 3 p 6 + ( 1 + ν 3 ) p 3 p 7 + p 4 p 8 + ν 2 p 4 2 + ( ν 1 + ν 2 ) p 4 p 5 + ( ν 2 + ν 4 ) p 4 p 6 + ( ν 2 + ν 3 ) p 4 p 7 + ν 2 p 4 p 8 + ( ν 1 + ν 4 ) p 5 p 6 + ( ν 1 + ν 3 ) p 5 p 7 + ν 1 p 5 p 8 + ( ν 3 + ν 4 ) p 6 p 7 + ν 4 p 6 p 8 + ν 3 p 7 p 8 .

Since p 1 < 0 and p 2 < 0, we have a < 0. Furthermore,

b = ( u 3 ξ S 10 + u 4 S 20 ) ( p 3 + ν 1 p 5 + ν 2 p 4 + ν 3 p 7 + ν 4 p 6 ) N 0 1 > 0 .

References

[1] T. Zheng, Y. Luo, X. Zhou, L. Zhang, and Z. Teng, “Spatial dynamic analysis for COVID-19 epidemic model with diffusion and Beddington-DeAngelis type incidence,” Commun. Pure Appl. Anal., vol. 22, no. 2, pp. 365–396, 2021, https://doi.org/10.3934/cpaa.2021154.Suche in Google Scholar

[2] S. Saha, G. Samanta, and J. J. Nieto, “Epidemic model of COVID-19 outbreak by inducing behavioural response in population,” Nonlinear Dyn., vol. 102, no. 1, pp. 455–487, 2020. https://doi.org/10.1007/s11071-020-05896-w.Suche in Google Scholar PubMed PubMed Central

[3] WHO Coronavirus (COVID-19) Dashboard, 2023 [Online]. Available at: https://covid19.who.int Accessed: Jul. 8, 2023.Suche in Google Scholar

[4] S. Saha and G. Samanta, “Modelling the role of optimal social distancing on disease prevalence of COVID-19 epidemic,” Int. J. Dyn. Control, vol. 9, no. 3, pp. 1053–1077, 2021. https://doi.org/10.1007/s40435-020-00721-z.Suche in Google Scholar PubMed PubMed Central

[5] P. M. Mphekgwana, M. Makgahlela, and T. M. Mothiba, “Use of traditional medicines to fight COVID-19 during the South African nationwide lockdown: a prevalence study among university students and academic staff,” Open Public Health J., vol. 14, no. 1, pp. 441–445, 2021, https://doi.org/10.2174/1874944502114010441.Suche in Google Scholar

[6] A. W. Adunimay and T. A. Ojo, “Western centric medicine for Covid-19 and its contradictions: can African alternate solutions be the cure?” Front. Polit. Sci., vol. 4, p. 835238, 2022, https://doi.org/10.3389/fpos.2022.835238.Suche in Google Scholar

[7] E. O. J. Ozioma and O. A. N. Chinwe, “Herbal medicines in African traditional medicine,” Herbal Med., vol. 10, pp. 191–214, 2019, https://doi.org/10.5772/intechopen.80348.Suche in Google Scholar

[8] S. Mutola, N. V. Pemunta, and N. V. Ngo, “Utilization of traditional medicine and its integration into the healthcare system in Qokolweni, South Africa; prospects for enhanced universal health coverage,” Complement. Therap. Clin. Pract., vol. 43, pp. 1–4, May 2021. https://doi.org/10.1016/j.ctcp.2021.101386.Suche in Google Scholar PubMed

[9] V. P. Titanji, “COVID-19 Response: the case for phytomedicines in Africa with particular focus on Cameroon,” J. Cameroon Acad. Sci., vol. 17, no. 2, pp. 163–175, 2021, https://doi.org/10.4314/jcas.v17i2.6.Suche in Google Scholar

[10] WHO Traditional Medicine Strategy: 2014–2023, 2013 [Online]. Available at: https://www.who.int/publications/i/item/9789241506096 Accessed: May 15, 2023.Suche in Google Scholar

[11] K. H. Ndukong, COVID-19 Treatment: Endogenous Cures Can Also Do the Trick! 2020 [Online]. Available at: http://en.people.cn/n3/2020/0526/c90000-9694588.html Accessed: Nov. 27, 2022.Suche in Google Scholar

[12] S. Saha, P. Dutta, and G. Samanta, “Dynamical behavior of SIRS model incorporating government action and public response in presence of deterministic and fluctuating environments,” Chaos Solit. Fractals, vol. 164, p. 112643, November 2022. https://doi.org/10.1016/j.chaos.2022.112643.Suche in Google Scholar

[13] P. Harjule, V. Tiwari, and A. Kumar, “Mathematical models to predict COVID-19 outbreak: an interim review,” J. Interdis. Math., vol. 24, no. 2, pp. 259–284, 2021, https://doi.org/10.1080/09720502.2020.1848316.Suche in Google Scholar

[14] M. Massard, R. Eftimie, A. Perasso, and B. Saussereau, “A multi-strain epidemic model for COVID-19 with infected and asymptomatic cases: application to French data,” J. Theor. Biol., vol. 545, p. 111117, July 2022, https://doi.org/10.1016/j.jtbi.2022.111117.Suche in Google Scholar PubMed PubMed Central

[15] C. H. Nkwayep, S. Bowong, J. Tewa, and J. Kurths, “Short-term forecasts of the COVID-19 pandemic: a study case of Cameroon,” Chaos Solit. Fractals, vol. 140, p. 110106, November 2020, https://doi.org/10.1016/j.chaos.2020.110106.Suche in Google Scholar PubMed PubMed Central

[16] T. Piasecki, P. B. Mucha, and M. Rosińska, “On limits of contact tracing in epidemic control,” Plos One, vol. 16, no. 8, pp. 1–21, 2021, https://doi.org/10.1371/journal.pone.0256180.Suche in Google Scholar PubMed PubMed Central

[17] C. Tadmon and S. Foko, “A transmission dynamics model of Covid-19: case of Cameroon,” Infect. Dis. Model., vol. 7, no. 2, pp. 211–249, 2022. https://doi.org/10.1016/j.idm.2022.05.002.Suche in Google Scholar PubMed PubMed Central

[18] Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, 2022 [Online]. Available at: https://www.covid19treatmentguidelines.nih.gov/overview/overview-of-covid-19 Accessed: Jul. 16, 2022.Suche in Google Scholar

[19] S. Busenberg and K. Cooke, Vertically Transmitted Diseases: Models and Dynamics, vol. 23, Berlin, Germany, Springer Science & Business Media, 2012.Suche in Google Scholar

[20] R. Ouifki and J. Banasiak, “Epidemiological models with quadratic equation for endemic equilibria—a bifurcation atlas,” Math. Methods Appl. Sci., vol. 43, no. 18, pp. 1–17, 2020, https://doi.org/10.1002/mma.6389.Suche in Google Scholar

[21] COVID-19 Statistics in South Africa, 2022 [Online]. Available at: https://sacoronavirus.co.za Accessed: Apr. 4, 2022.Suche in Google Scholar

[22] M. Chapwanya, J. Lubuma, Y. Terefe, and B. Tsanou, “Analysis of war and conflict effect on the transmission dynamics of the Tenth Ebola outbreak in the Democratic Republic of Congo,” Bull. Math. Biol., vol. 84, no. 12, p. 136, 2022, https://doi.org/10.1007/s11538-022-01094-4.Suche in Google Scholar PubMed

[23] South Africa Population, 2022 [Online]. Available at: https://countrymeters.info/en/South_Africa#population_2022 Accessed: Jul. 21, 2022.Suche in Google Scholar

[24] M. M. Ojo, T. O. Benson, O. J. Peter, and E. F. D. Goufo, “Nonlinear optimal control strategies for a mathematical model of COVID-19 and influenza co-infection,” Phys. A Stat. Mech. Appl., vol. 607, p. 128173, 1 December 2022, https://doi.org/10.1016/j.physa.2022.128173.Suche in Google Scholar PubMed PubMed Central

[25] S. Marino, I. B. Hogue, C. J. Ray, and D. E. Kirschner, “A methodology for performing global uncertainty and sensitivity analysis in systems biology,” J. Theor. Biol., vol. 254, no. 1, pp. 178–196, 2008, https://doi.org/10.1016/j.jtbi.2008.04.011.Suche in Google Scholar PubMed PubMed Central

[26] R. Taylor, “Interpretation of the correlation coefficient: a basic review,” J. Diagn. Med. Sonogr., vol. 6, no. 1, pp. 35–39, 1990, https://doi.org/10.1177/875647939000600106.Suche in Google Scholar

[27] J. P. LaSalle, The Stability of Dynamical Systems, Philadelphia, SIAM, 1976.10.21236/ADA031020Suche in Google Scholar

[28] C. Castillo-Chavez and B. Song, “Dynamical models of tuberculosis and their applications,” Math. Biosci. Eng, vol. 1, no. 2, pp. 361–404, 2004, https://doi.org/10.3934/mbe.2004.1.361.Suche in Google Scholar PubMed

[29] S. Saha, G. Samanta, and J. J. Nieto, “Impact of optimal vaccination and social distancing on COVID-19 pandemic,” Math. Comput. Simul., vol. 200, pp. 285–314, 2022. https://doi.org/10.1016/j.matcom.2022.04.025.Suche in Google Scholar PubMed PubMed Central

Received: 2023-07-22
Accepted: 2024-02-03
Published Online: 2024-03-11

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jncds-2023-0062/html
Button zum nach oben scrollen